{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:49:51Z","timestamp":1787021391847,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1245\/s10434-025-17149-4","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T11:12:53Z","timestamp":1742555573000},"page":"4388-4395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Gender and Age as Preoperative Predictors of Early Disease Progression in Patients Undergoing Surgery for Pancreatic Neuroendocrine Tumors with Liver Metastases"],"prefix":"10.1245","volume":"32","author":[{"given":"Stefano","family":"Partelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Andreasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Battistella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Tamburrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Pecorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Falconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"issue":"10","key":"17149_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335\u201342. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0589.","journal-title":"JAMA Oncol"},{"issue":"4","key":"17149_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s40618-021-01705-2","volume":"45","author":"V Andreasi","year":"2022","unstructured":"Andreasi V, Ricci C, Partelli S, et al. Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis. J Endocrinol Invest. 2022;45(4):705\u201318. https:\/\/doi.org\/10.1007\/s40618-021-01705-2.","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"17149_CR3","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/bjs\/znaa141","volume":"108","author":"C Ricci","year":"2021","unstructured":"Ricci C, Partelli S, Landoni L, et al. Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysis. Br J Surg. 2021;108(7):811\u20136. https:\/\/doi.org\/10.1093\/bjs\/znaa141.","journal-title":"Br J Surg"},{"issue":"3","key":"17149_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.hpb.2017.10.014","volume":"20","author":"S Partelli","year":"2018","unstructured":"Partelli S, Cirocchi R, Rancoita PMV, et al. A systematic review and meta-analysis on the role of palliative primary resection for pancreatic neuroendocrine neoplasm with liver metastases. HPB. 2018;20(3):197\u2013203. https:\/\/doi.org\/10.1016\/j.hpb.2017.10.014.","journal-title":"HPB"},{"issue":"2","key":"17149_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ejso.2016.09.011","volume":"43","author":"E Bertani","year":"2017","unstructured":"Bertani E, Fazio N, Radice D, et al. Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation. Eur J Surg Oncol. 2017;43(2):372\u20139. https:\/\/doi.org\/10.1016\/j.ejso.2016.09.011.","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"17149_CR6","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1245\/s10434-024-15316-7","volume":"31","author":"H Gudmundsdottir","year":"2024","unstructured":"Gudmundsdottir H, Fogliati A, Grotz TE, et al. Value of surgical cytoreduction in patients with small intestinal neuroendocrine tumors metastatic to the liver and peritoneum. Ann Surg Oncol. 2024;31(8):5370\u20136. https:\/\/doi.org\/10.1245\/s10434-024-15316-7.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"17149_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.surg.2018.04.070","volume":"165","author":"AT Scott","year":"2019","unstructured":"Scott AT, Breheny PJ, Keck KJ, et al. Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs). Surgery. 2019;165(1):166\u201375. https:\/\/doi.org\/10.1016\/j.surg.2018.04.070.","journal-title":"Surgery"},{"issue":"1","key":"17149_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.surg.2017.05.030","volume":"163","author":"RE Morgan","year":"2018","unstructured":"Morgan RE, Pommier SJ, Pommier RF. Expanded criteria for debulking of liver metastasis also apply to pancreatic neuroendocrine tumors. Surgery. 2018;163(1):218\u201325. https:\/\/doi.org\/10.1016\/j.surg.2017.05.030.","journal-title":"Surgery"},{"issue":"2","key":"17149_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/bjs.6468","volume":"96","author":"A Frilling","year":"2009","unstructured":"Frilling A, Li J, Malamutmann E, Schmid K-W, et al. Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease. Br J Surg. 2009;96(2):175\u201384. https:\/\/doi.org\/10.1002\/bjs.6468.","journal-title":"Br J Surg"},{"issue":"2","key":"17149_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/10.1159\/000443167","volume":"103","author":"M Pavel","year":"2016","unstructured":"Pavel M, O\u2019Toole D, Costa F, et al. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. 2016;103(2):172\u201385. https:\/\/doi.org\/10.1016\/10.1159\/000443167.","journal-title":"Neuroendocrinology"},{"issue":"3","key":"17149_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000464292","volume":"105","author":"S Partelli","year":"2017","unstructured":"Partelli S, Bartsch DK, Capdevila J, et al. ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology. 2017;105(3):255\u201365. https:\/\/doi.org\/10.1159\/000464292.","journal-title":"Neuroendocrinology"},{"issue":"7","key":"17149_CR12","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","volume":"31","author":"M Pavel","year":"2020","unstructured":"Pavel M, \u00d6berg K, Falconi M, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(7):844\u201360. https:\/\/doi.org\/10.1016\/j.annonc.2020.03.304.","journal-title":"Ann Oncol"},{"issue":"6","key":"17149_CR13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1159\/000503721","volume":"110","author":"AK Clift","year":"2020","unstructured":"Clift AK, Kidd M, Bodei L, et al. Neuroendocrine neoplasms of the small bowel and pancreas. Neuroendocrinology. 2020;110(6):444\u201376. https:\/\/doi.org\/10.1159\/000503721.","journal-title":"Neuroendocrinology"},{"issue":"12","key":"17149_CR14","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495\u20139. https:\/\/doi.org\/10.1016\/j.ijsu.2014.07.013.","journal-title":"Int J Surg"},{"key":"17149_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Litiere S, de Vries E, et al. RECIST 1.1-Update and clarification: from the RECIST committee. Eur J Cancer. 2016;62:132\u20137. https:\/\/doi.org\/10.1016\/j.ejca.2016.03.081.","journal-title":"Eur J Cancer"},{"issue":"3","key":"17149_CR16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.surg.2014.06.016","volume":"156","author":"JAMG Tol","year":"2014","unstructured":"Tol JAMG, Gouma DJ, Bassi C, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the international study group on pancreatic surgery (ISGPS). Surgery. 2014;156(3):591\u2013600. https:\/\/doi.org\/10.1016\/j.surg.2014.06.016.","journal-title":"Surgery"},{"issue":"2","key":"17149_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg"},{"issue":"3","key":"17149_CR18","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.surg.2016.11.014","volume":"161","author":"C Bassi","year":"2017","unstructured":"Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the international study group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161(3):584\u201391. https:\/\/doi.org\/10.1016\/j.surg.2016.11.014.","journal-title":"Surgery"},{"key":"17149_CR19","volume-title":"WHO classification of tumours. Digestive system tumours","author":"WHO Classification of Tumours Editorial Board","year":"2019","unstructured":"WHO Classification of Tumours Editorial Board. WHO classification of tumours. Digestive system tumours. 5th edn. Lyon: IARC Press; 2019.","edition":"5"},{"issue":"4","key":"17149_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/10.1007\/s00428-006-0250-1","volume":"449","author":"G Rindi","year":"2006","unstructured":"Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449(4):395\u2013401. https:\/\/doi.org\/10.1016\/10.1007\/s00428-006-0250-1.","journal-title":"Virchows Arch"},{"key":"17149_CR21","volume-title":"TNM classification of malignant tumours","year":"2017","unstructured":"Brierly JD, Gospodarowicz MK, Witteking C, editors. TNM classification of malignant tumours. 8th edn. Oxford, Hoboken, NJ: Wiley; 2017.","edition":"8"},{"issue":"13","key":"17149_CR22","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3390\/cancers16132376","volume":"16","author":"M Mortagy","year":"2024","unstructured":"Mortagy M, El Asmar ML, Chandrakumaran K, et al. Sex differences in the survival of patients with neuroendocrine neoplasms: a comparative study of two national databases. Cancers. 2024;16(13):2376. https:\/\/doi.org\/10.3390\/cancers16132376.","journal-title":"Cancers"},{"key":"17149_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jss.2024.07.012","volume":"302","author":"J Chang","year":"2024","unstructured":"Chang J, Suraju MO, Tran CG, et al. Association between female sex and better survival in gastroenteropancreatic neuroendocrine tumors. J Surg Res. 2024;302:53\u201363. https:\/\/doi.org\/10.1016\/j.jss.2024.07.012.","journal-title":"J Surg Res"},{"issue":"7","key":"17149_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2217\/cer-2021-0205","volume":"11","author":"O Abdel-Rahman","year":"2022","unstructured":"Abdel-Rahman O, Ghosh S, Fazio N. Sex-based differences in the outcomes of patients with lung carcinoids. J Comp Eff Res. 2022;11(7):523\u201331. https:\/\/doi.org\/10.2217\/cer-2021-0205.","journal-title":"J Comp Eff Res"},{"issue":"3","key":"17149_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11154-022-09719-8","volume":"23","author":"RM Ruggeri","year":"2022","unstructured":"Ruggeri RM, Altieri B, Grossrubatcher E, et al. Sex differences in carcinoid syndrome: a gap to be closed. Rev Endocr Metab Disord. 2022;23(3):659\u201369. https:\/\/doi.org\/10.1007\/s11154-022-09719-8.","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"17149_CR26","first-page":"921","volume":"36","author":"N Zimmerman","year":"2016","unstructured":"Zimmerman N, Lazar-Karsten P, Keck T, Billmann F, Schmid S, Brabant G, et al. Expression pattern of CDX2, estrogen and progesterone receptors in primary gastroenteropancreatic neuroendocrine tumors and metastases. Anticancer Res. 2016;36(3):921\u20134.","journal-title":"Anticancer Res"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17149-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17149-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17149-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T12:14:54Z","timestamp":1746274494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17149-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["17149"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17149-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Stefano Partelli, Valentina Andreasi, Anna Battistella, Domenico Tamburrino, Nicol\u00f2 Pecorelli, Stefano Crippa, and Massimo Falconi have no disclosures to declare that may be relevant to the contents of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}